Artivion, INC Form 4 insider transactions

NYSE
Artivion's CEO, James P. Mackin, sold shares of common stock on February 24, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
NYSE
Jean F. Holloway, SVP and General Counsel of Artivion, Inc., sold shares of common stock on February 24, 2025, to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
Artivion's Chief Commercial Officer, John E. Davis, sold shares of common stock to cover tax withholding obligations arising from the vesting of restricted stock units.
NYSE
Lance A. Berry, Executive VP and CFO of Artivion, Inc., sold 3,259 shares of common stock on February 24, 2025, to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., reports selling shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
Artivion Inc.'s VP, Chief Accounting Officer, Amy Horton, gifted 1,100 common shares to a charity on December 12, 2024.
NYSE
Jean F. Holloway, SVP and General Counsel at Artivion Inc., sold 8,070 shares of common stock in a recent open market transaction.
NYSE
Artivion Inc. files an amendment to correct an administrative error in reporting the number of shares sold to cover tax obligations on December 6, 2024.
NYSE
Artivion Inc.'s VP, Chief Accounting Officer, Amy Horton, sold 4,329 shares of common stock to cover tax obligations related to vesting restricted stock units.
NYSE
Andrew M. Green, VP of Regulatory at Artivion, Inc., sold 7,618 shares of common stock at $30 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Amy Horton, VP, Chief Accounting Officer of Artivion, Inc., reports the sale of 12,430 shares of common stock on October 1, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
Jean F. Holloway, SVP, General Counsel of Artivion, Inc., reported the sale of 3,167 shares of common stock at an average price of $26.5538 on August 26, 2024.
NYSE
Matthew Getz, VP of Human Resources at Artivion, Inc., reports the sale of common stock units on August 16, 2024.
NYSE
Jean F. Holloway, SVP, General Counsel of Artivion, Inc., sold 2,383 shares of common stock on August 15, 2024, at a price of $25.7629 per share.
NYSE
Director Anthony B. Semedo of Artivion Inc. (AORT) sold 9,709 shares of common stock at a price of $24.99 per share on August 13, 2024.
NYSE
Director Thomas Ackerman acquired 6,289 shares of Artivion, Inc. common stock through the vesting of a restricted stock award.
NYSE
Director Daniel J. Bevevino acquired 6,289 shares of Artivion, Inc. through a restricted stock grant that vests on May 30, 2025.
NYSE
Director Jon W. Salveson reports acquiring 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.
NYSE
Director James Bullock acquired 6,289 shares of Artivion, Inc. common stock through a restricted stock award that vests on May 30, 2025.
NYSE
Director Jeffrey H. Burbank reports acquiring 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.
NYSE
Director Marna Borgstrom reports acquiring and disposing of Artivion, Inc. common stock on May 30, 2024.
NYSE
Director Anthony B. Semedo reports acquisition of 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.
NYSE
Director Elizabeth A. Hoff acquired 6,289 shares of Artivion, Inc. on May 30, 2024, as part of a restricted stock award.
NYSE
Jean F. Holloway, SVP, General Counsel of Artivion, Inc., sold 1,250 shares of common stock at a price of $23.4201 per share on May 10, 2024.
NYSE
Jean F. Holloway, SVP, General Counsel of Artivion, Inc., sold 979 shares of common stock on May 9, 2024, at a price of $23.785 per share.
NYSE
Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., sold 2,183 shares of common stock on March 20, 2024, to cover tax withholding obligations.
NYSE
Andrew M. Green, VP Regulatory at Artivion, Inc., sold 1,462 shares of common stock at $20 per share on March 15, 2024, according to a Form 4 filing.
NYSE
Andrew M. Green, VP Regulatory at Artivion, Inc., sold 3,994 shares of common stock at $20 per share on March 14, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
Matthew A. Getz, VP of Human Resources at Artivion, Inc., sold 5,000 shares of common stock on March 12, 2024, at an average price of $19.9439 per share.
NYSE
Amy Horton, VP and Chief Accounting Officer of Artivion Inc., files an amended Form 4 to correct the number of shares sold to cover tax withholding obligations.